Buy hair-loss medication online — finasteride, dutasteride, oral and topical minoxidil, combination foams and the Hair Loss Stack, plus tamsulosin + 5α-reductase BPH/hair combination products. Androgenetic alopecia (male-pattern baldness) is the most common form of hair loss in men, driven by dihydrotestosterone (DHT) miniaturisation of scalp follicles in genetically susceptible scalps. Two FDA-approved drug classes treat it: 5α-reductase inhibitors (finasteride, dutasteride) lower DHT at the follicle, and minoxidil directly stimulates the dermal papilla regardless of androgen status. Maximum benefit comes from combining the two; typical visible regrowth begins at 3–6 months and plateaus at 12 months.
Finasteride 1 mg — the cornerstone oral therapy for male-pattern baldness. Lowers scalp DHT by ~70% via type-II 5α-reductase inhibition. Brands: Finpecia (Cipla, the most widely studied generic), Finrest, Proscalpin. Continued use is required — benefit reverses within 6–12 months of stopping. Sexual side effects (lowered libido, erectile difficulty) occur in 1–3% of men and usually reverse on discontinuation, though post-finasteride syndrome reports persist in a small minority.
Finasteride 5 mg (Proscar) — off-label hair-loss option. Proscar is licensed for benign prostatic hyperplasia (BPH) at 5 mg but is sometimes split or used at full strength off-label for hair when 1 mg has plateaued. Discuss split-dosing strategy with a clinician — not all 5 mg tablets are scored or evenly divisible.
Dutasteride — the more potent 5α-reductase inhibitor (blocks both type-I and type-II isoenzymes; ~90% scalp DHT reduction vs ~70% with finasteride). Off-label for hair loss in most jurisdictions, FDA-approved for BPH only. Dutanol (dutasteride 0.5 mg). Considered for men who plateau on finasteride or who want maximum 5α-reductase suppression. Sexual side-effect profile is similar to finasteride but slightly higher numerically.
Topical minoxidil — the foundation of all hair-loss combination protocols. Applied directly to the scalp, no systemic absorption to speak of, no sexual side effects. 5% strength is standard for men. Mintop Lotion (Cipla 2% / 5% / 10% solutions), Regaine 5% (the original Pfizer/J&J brand), Tugain Foam, Tugain Solution. Initial shed (months 1–2) is normal — resting follicles cycling out before regrowth phase. Foam preferred for sensitive scalp; solution penetrates better but contains propylene glycol.
Oral minoxidil — the off-label alternative for non-responders to topical or for ease-of-use. Low-dose oral minoxidil (LDOM) at 0.625–5 mg daily has emerged as a serious clinical option for androgenetic alopecia, especially when topical adherence is poor. Minoxytop is an oral minoxidil 5 mg tablet used off-label for male and female pattern hair loss; works systemically via the same mechanism as topical but reaches all follicles uniformly. Side-effect surveillance for oedema, hypertrichosis (unwanted body hair), and tachycardia recommended. The same molecule at 10 mg twice daily is licensed for resistant hypertension — the hair-loss dose is much lower.
Hair Loss Stack — finasteride + minoxidil bundle. Hair Loss Stack bundles Finpecia (finasteride 1 mg) with Tugain Foam (minoxidil 5%) at 1-month, 3-month, and 6-month tier pricing. Combination therapy outperforms either monotherapy and is the modern standard of care for sustained regrowth.
Combination products with BPH adjunct (tamsulosin + 5α-reductase inhibitor). Tamsulosin is an alpha-1A blocker that relaxes prostate smooth muscle — primary indication is BPH urinary symptoms, but the 5α-reductase partner does contribute to scalp follicle preservation. Veltam F (tamsulosin + finasteride), Veltam Plus (tamsulosin + dutasteride), Urimax D (tamsulosin + dutasteride), Temsunol F (tamsulosin + finasteride). Useful for men managing BPH and hair loss simultaneously; not a hair-loss-first choice.
How to choose. Early diffuse thinning, age 25–40, no comorbidity → finasteride 1 mg + topical minoxidil 5% (Hair Loss Stack). Plateau on finasteride at 12 months → switch to dutasteride or add oral minoxidil. Topical minoxidil non-adherence or scalp irritation → switch to low-dose oral minoxidil. BPH plus hair loss → tamsulosin + 5α-reductase combination. Female pattern hair loss → minoxidil monotherapy first (finasteride is contraindicated in women of reproductive age). Set realistic expectations: hair-loss therapy is preventive plus modestly regenerative, not curative; results plateau and require lifelong commitment to maintain.
All MedsBase hair-loss medications are FDA-approved generics manufactured by WHO-GMP certified producers. Worldwide shipping. Loyalty points apply on every order.
2026 buyer’s guide: See our shortlist Best Hair Loss Treatments 2026: Finasteride, Dutasteride & More for ranked picks, comparison table, dosing notes and decision shortcut.